NCT06813131Completed
Impact of Medical Nutrition Therapy and Follow-Up Frequency on Metabolic Syndrome Parameters
The Effect of Medical Nutrition Therapy and Follow-Up Frequency on Parameters Related to Metabolic Syndrome in Individuals With Metabolic Syndrome: A Randomized Controlled Trial
Source: ClinicalTrials.gov · Last updated 6 Feb 2025
Brief summary (registry, in English)
There is no study that has investigated the effects of medical nutrition therapy and more frequent follow-up via telehealth on metabolic syndrome parameters in patients with MetS who have multiple metabolic disorders such as being overweight, prediabetic/diabetic, dyslipidemic and having increased blood pressure. This study was conducted to examine the effects of medical nutrition therapy and increased follow-up via telephone calls on MetS-related parameters in individuals with MetS.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 93 (actual)
- First submitted
- 28 Jan 2025
- Start date
- 14 Oct 2023
- Primary completion date
- 5 Jul 2024
- Lead sponsor
- Hacettepe University
- Diseases
- Obesity
- NCT number
- NCT06813131
What you commit to
- Study type: Interventional
- Participants enrolled: 93
- From 14 Oct 2023 to the primary completion date, 5 Jul 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Having kidney failure,
- Having liver failure,
- Having immune failure
- Having chronic gastrointestinal system disease
- Having cancer
- Having type 1 diabetes
Other
- Taking anti diabetic agents other then metformin
- Taking anti hyperlipidemic agents
- Taking anti hypertensive agents
- Using food supplements (w-3, chromium, multivitamins) that could affect metabolic parameters,
- Being pregnant or breastfeeding.
Who the study is looking for
- Individuals with HbA1c values \<8.5%
- Diagnosed with MetS by a physician according to the criteria declared by the consensus of the "International Diabetes Federation Task Force on Epidemiology and Prevention, National Heart, Lung, and Blood Institute, American Heart Association, World Heart Federation, International Atherosclerosis Society, and International Association for the Study of Obesity" were included.
Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Goztepe Prof. Dr. Suleyman Yalcin City Hospital Coordinator of this site? Confirm its status | Istanbul | Turkey (Türkiye) | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.